Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

New Software Simplifies Performing and Analyzing Dissolution via HPLC

By BiotechDaily International staff writers
Posted on 22 May 2013
Image: The Agilent LC Dissolution Software module (Photo courtesy of Agilent Technologies).
Image: The Agilent LC Dissolution Software module (Photo courtesy of Agilent Technologies).
A new software module simplifies the quantification and reporting of dissolution samples analyzed by HPLC, maximizing the user's investment in dissolution apparatus, liquid chromatographs, and informatics.

Agilent Technologies Inc. (Santa Clara, CA, USA) now offers the new “LC Dissolution Software,” an add-on module for use with the ChemStation Edition of the Agilent OpenLAB Chromatography Data System. Once dissolution samples have been collected, they are loaded into the chromatograph and analyzed. The LC Dissolution Software module automates the setup of the chromatograph, incorporates the dissolution methodology, performs the sample analysis, and generates the final reports. Real-time views of the dissolution profile of all active ingredients are available as the analysis progresses.

"Customers can maximize their current workflow by integrating dissolution with LC analysis using LC Dissolution Software," said Allan Little, Agilent director of marketing for dissolution systems; "This software eliminates the need to export data to a spreadsheet and thus ensures the integrity and security of dissolution analysis data, all in a 21 CFR Part 11 environment."

Additional key product features include existing chromatographic methods that easily integrate for automatic generation of analysis sequences, sequence generation independent of hardware, and full utilization of all Agilent LC ChemStation software capabilities.

Related Links:

Agilent Technologies
LC Dissolution Software



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: The new peptide offers a triple hormone effect in a single-cell molecule (Photo courtesy of Indiana University).

Tripeptide Drug Effectively Controls Metabolic Syndrome in Rodent Model

Promising results in reducing obesity and normalizing glucose metabolism obtained with a synthetic dipeptide drug have been enhanced by the addition of a molecule of a third hormone, glucagon.... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.